2590-1125

Clinical Parkinsonism & Related Disorders

Elsevier

View prefix report (10.1016)

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 477 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact477 DOIs
2

Attach ORCID iDs across 286 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact286 DOIs
3

Deposit reference lists for 10 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact10 DOIs

DOIs for this ISSN

Showing the top 5 of 477 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Huntington disease: Advances in the understanding of its mec… (10.1016/j.prdoa.2020.100056)
Abstract ORCID
85.80 51
2 Corticobasal degeneration and corticobasal syndrome: A revie… (10.1016/j.prdoa.2019.08.005)
Abstract ORCID
83.14 45
3 Nutritional ketosis for mild cognitive impairment in Parkins… (10.1016/j.prdoa.2019.07.006)
Abstract ORCID
81.67 42
4 An overview of pain in Parkinson's disease (10.1016/j.prdoa.2019.11.004)
Abstract ORCID
78.41 36
5 A vicious cycle of fear of falling avoidance behavior in Par… (10.1016/j.prdoa.2021.100089)
Abstract ORCID
78.41 36
6 Prediction of cognitive progression in Parkinson's disease u… (10.1016/j.prdoa.2019.08.006)
Abstract ORCID
75.93 32
7 Abnormalities of smooth pursuit in Parkinson’s disease: A sy… (10.1016/j.prdoa.2020.100085)
Abstract ORCID
75.26 31
8 Eye movement abnormalities in movement disorders (10.1016/j.prdoa.2019.08.004)
Abstract ORCID
74.57 30
9 Continuous subcutaneous foslevodopa/foscarbidopa infusion fo… (10.1016/j.prdoa.2024.100239)
Abstract ORCID
74.57 30
10 Frailty in Parkinson’s disease: A systematic review and meta… (10.1016/j.prdoa.2021.100095)
Abstract ORCID
73.12 28
11 Dopamine agonists in Parkinson’s disease: Impact of D1-like… (10.1016/j.prdoa.2023.100212)
Abstract ORCID
73.12 28
12 Successful implementation of technology in the management of… (10.1016/j.prdoa.2023.100188)
Abstract ORCID
71.57 26
13 Targeting neurons in the gastrointestinal tract to treat Par… (10.1016/j.prdoa.2019.06.001)
Abstract ORCID
69.01 23
14 Essential tremor: New advances (10.1016/j.prdoa.2019.100031)
Abstract ORCID
67.12 21
15 Social cognition in cervical dystonia: A case-control study (10.1016/j.prdoa.2020.100072)
Abstract ORCID
67.12 21
16 Severity of depressive and motor symptoms impacts quality of… (10.1016/j.prdoa.2022.100180)
Abstract ORCID
66.11 20
17 Identifying incident Parkinson's disease using administrativ… (10.1016/j.prdoa.2020.100061)
Abstract ORCID
60.21 15
18 Self-perceptions of speech, voice, and swallowing in motor p… (10.1016/j.prdoa.2020.100074)
Abstract ORCID
60.21 15
19 Continuous subcutaneous apomorphine infusion in the early ph… (10.1016/j.prdoa.2021.100129)
Abstract ORCID
60.21 15
20 Neural synchronization analysis of electroencephalography co… (10.1016/j.prdoa.2022.100140)
Abstract ORCID
60.21 15
21 Mood disorder affects age at onset of adult-onset cervical d… (10.1016/j.prdoa.2020.100049)
Abstract ORCID
58.80 14
22 Patient perceptions and knowledge of Parkinson's disease and… (10.1016/j.prdoa.2020.100038)
Abstract ORCID
57.31 13
23 Burst spinal cord stimulation for pain and motor function in… (10.1016/j.prdoa.2020.100043)
Abstract ORCID
57.31 13
24 A bidirectional relationship between anxiety, depression and… (10.1016/j.prdoa.2021.100104)
Abstract ORCID
57.31 13
25 Spatial variability and directional shifts in postural contr… (10.1016/j.prdoa.2024.100249)
Abstract ORCID
55.70 12
26 Use of a medication-based algorithm to identify advanced Par… (10.1016/j.prdoa.2020.100046)
Abstract ORCID
53.96 11
27 The experience of off periods: Qualitative analysis of inter… (10.1016/j.prdoa.2019.07.008)
Abstract ORCID
52.07 10
28 Adherence to a strict medication protocol can reduce length… (10.1016/j.prdoa.2020.100076)
Abstract ORCID
52.07 10
29 Long-term outcomes with pimavanserin for psychosis in clinic… (10.1016/j.prdoa.2022.100143)
Abstract ORCID
52.07 10
30 A pilot study of machine learning of resting-state EEG and d… (10.1016/j.prdoa.2022.100166)
Abstract ORCID
52.07 10
31 Efficacy of virtual reality-based cognitive behavioral group… (10.1016/j.prdoa.2025.100316)
Abstract ORCID
52.07 10
32 Impact of abobotulinumtoxinA on the clinical features of cer… (10.1016/j.prdoa.2020.100063)
Abstract ORCID
50.00 9
33 Tremor analysis with wearable sensors correlates with outcom… (10.1016/j.prdoa.2020.100066)
Abstract ORCID
50.00 9
34 Non-pharmacologic interventions to treat apathy in Parkinson… (10.1016/j.prdoa.2021.100096)
Abstract ORCID
50.00 9
35 An intensive exercise-based training program reduces prefron… (10.1016/j.prdoa.2021.100128)
Abstract ORCID
50.00 9
36 Prediction of early-wheelchair dependence in multiple system… (10.1016/j.prdoa.2023.100183)
Abstract ORCID
50.00 9
37 Coupling neurologic music therapy with immersive virtual rea… (10.1016/j.prdoa.2024.100277)
Abstract ORCID
50.00 9
38 New insights into facial emotion recognition in Parkinson's… (10.1016/j.prdoa.2019.11.003)
Abstract ORCID
47.71 8
39 Parkinsonism and chronic manganese exposure: Pilot study wit… (10.1016/j.prdoa.2020.100057)
Abstract ORCID
47.71 8
40 Dopamine genetic risk score predicts impulse control behavio… (10.1016/j.prdoa.2021.100113)
Abstract ORCID
47.71 8
41 Blood pressure variability in Parkinson's Disease patients –… (10.1016/j.prdoa.2023.100191)
Abstract ORCID
47.71 8
42 Partners' view after subthalamic deep brain stimulation: Bet… (10.1016/j.prdoa.2020.100052)
Abstract ORCID
45.15 7
43 Alarming levels of stigma toward generalized dystonia: A cro… (10.1016/j.prdoa.2020.100059)
Abstract ORCID
45.15 7
44 Personalized care management for persons with Parkinson's di… (10.1016/j.prdoa.2020.100070)
Abstract ORCID
45.15 7
45 Characteristics of advanced Parkinson's disease patients see… (10.1016/j.prdoa.2020.100075)
Abstract ORCID
45.15 7
46 Trends and outcomes associated with gastrostomy tube placeme… (10.1016/j.prdoa.2020.100088)
Abstract ORCID
45.15 7
47 The effect of GLP-1 receptor agonists in pre-clinical rodent… (10.1016/j.prdoa.2022.100133)
Abstract ORCID
45.15 7
48 Differentiation of Parkinson’s disease tremor and essential… (10.1016/j.prdoa.2022.100146)
Abstract ORCID
45.15 7
49 Levodopa-Carbidopa Intestinal Gel may improve treatment-resi… (10.1016/j.prdoa.2022.100148)
Abstract ORCID
45.15 7
50 Imaging pathological tau in atypical parkinsonisms: A review (10.1016/j.prdoa.2022.100155)
Abstract ORCID
45.15 7